Skip to main content
J

Jinhe Biotechnology CO.,LTD. — Investor Relations & Filings

Ticker · 002688 Shenzhen Stock Exchange Manufacturing
Filings indexed 1,825 across all filing types
Latest filing 2025-11-03 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 002688

About Jinhe Biotechnology CO.,LTD.

https://www.jinhe.com.cn

Jinhe Biotechnology CO.,LTD. specializes in the research, development, and manufacturing of animal health products and feed additives. The company is a prominent global producer of chlortetracycline (CTC), maintaining extensive production capacity for feed-grade antibiotics. Its diverse product portfolio includes veterinary pharmaceuticals such as salinomycin and monensin, alongside a range of biological products and animal vaccines. Jinhe Biotechnology leverages advanced fermentation technology and integrated research capabilities to provide solutions for the livestock and poultry sectors. The company focuses on improving animal growth performance and disease prevention through standardized production processes and a global distribution network. Its operations span the development of specialized additives and the provision of comprehensive veterinary medical products designed to support large-scale animal husbandry.

Recent filings

Filing Released Lang Actions
关于获得饲料添加剂产品批准文号的公告
Regulatory Filings
2025-11-03 Chinese
关于金河生物科技股份有限公司二零二五年第五次临时股东大会的法律意见书
Regulatory Filings
2025-10-31 Chinese
第六届董事会第三十四次会议决议公告
Regulatory Filings
2025-10-31 Chinese
2025年第五次临时股东大会决议的公告
Regulatory Filings
2025-10-31 Chinese
关于董事、副总经理辞任暨选举职工董事、补选董事会专门委员会委员的公告
Regulatory Filings
2025-10-31 Chinese
关于控股股东部分股份质押及解除质押的公告
Regulatory Filings
2025-10-30 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.